Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Huang, San Diego
Ai-Mei Huang, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110129015 | HIERARCHICAL MOTION VECTOR PROCESSING METHOD, SOFTWARE AND DEVICES - A preferred method for hierarchical motion vector processing determines reliability levels of blocks in image data according to residual energy levels. Macroblocks of an image frame are merged according to reliability levels of the motion vectors of blocks. Single motion vectors are selected for merged macroblocks. Motion vectors of blocks merged in the step of merging are iteratively assigned by minimizing the bi-directional prediction difference on successively smaller merged blocks. The reliability levels are preferably determined by measure residual energy of both chrominance and luminance components. In preferred embodiments, motion vector correlation is used to assist the MV reliability classification and the merging and iterative assignment. Refinement and smoothing can be conducted on successively finer block sizes. Additionally, preferred methods account for occlusions by choosing only one of forward or backward prediction for occlusion regions depending upon the class of the occlusion. Results of motion vector classification of the invention can be used in motion compensated frame interpolation and other techniques. | 06-02-2011 |
Chengchang Huang, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080261594 | COMPLETE MESSAGE DELIVERY TO MULTI-MODE COMMUNICATION DEVICE - A system and method for complete message delivery to a multi-mode communication device is presented. The communication device is adaptable to communicate with one or more carrier networks and one or more data networks. When a new message is received for the communication device, a message notification is sent to the device via a first network. The communication device parses the message notification and retrieves the complete message via a second network. Alternatively, the message notification may be delivered and the complete message may be retrieved via the same network. | 10-23-2008 |
Dehua Huang, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080293684 | Heterocyclic Acetophenone Potentiators of Metabotropic Glutamate Receptors - The present invention is directed to compounds which are potentiators of metabotropic glutamate receptors, including the mGluR2 receptor, and which are useful in the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which metabotropic glutamate receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which metabotropic glutamate receptors are involved. | 11-27-2008 |
| 20090023724 | Heteroaryl compounds, compositions thereof, and methods of treatment therewith - Provided herein are Heteroaryl Compounds having the following structure: | 01-22-2009 |
| 20090203903 | Thiazolyl mglur5 antagonists and methods for their use - The identification of a unique series of compounds which possesses special advantages in terms of drug-like properties due to their possessing advantageous properties in terms of potency and/or pharmacokinetic and/or selectivity and/or in vivo receptor occupancy properties. Specifically, the selection of a 1,3-thiazol-2-yl ring member linked by an ethynylene to the 3 position of a pyridyl ring or the 5 position of a pyrimidinyl ring, wherein the ring is substituted with selected substituents, results in a compound having superior drug-like properties. The invention includes pharmaceutically acceptable salt forms of these heterocyclic compounds, in particular chloride salts and trifluoroacetate salts. | 08-13-2009 |
| 20110230526 | Thiazolyl Mglur5 Antagonists and Methods for Their Use - The identification of a unique series of compounds which possesses special advantages in terms of drug-like properties due to their possessing advantageous properties in terms of potency and/or pharmacokinetic and/or selectivity and/or in vivo receptor occupancy properties. Specifically, the selection of a 1,3-thiazol-2-yl ring member linked by an ethynylene to the 3 position of a pyridyl ring or the 5 position of a pyrimidinyl ring, wherein the ring is substituted with selected substituents, results in a compound having superior drug-like properties. The invention includes pharmaceutically acceptable salt forms of these heterocyclic compounds, in particular chloride salts and trifluoroacetate salts. | 09-22-2011 |
| 20110245245 | METHODS OF TREATMENT COMPRISING THE ADMINISTRATION OF HETEROARYL COMPOUNDS - Provided herein are Heteroaryl Compounds having the following structure: | 10-06-2011 |
Fei Huang, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100080555 | METHOD AND ARCHITECTURE FOR PROVIDING HIGH BANDWIDTH BROADBAND COMMUNICATION TO FAST MOVING USERS - A wireless communication network architecture | 04-01-2010 |
Helen Grace Huang, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100304471 | ASSAY - The present invention relates to test devices, and in particular devices capable of detecting the presence or absence of an analyte in a sample, such as a liquid sample. Also provided are methods of using such devices for quantitative or qualitative measurement of one or more analytes in a liquid sample. | 12-02-2010 |
Jen-Sheng Huang, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100081393 | APPARATUS, SYSTEM, AND METHODS FOR HANDLING ATTACH PROCEDURE IN MOBILE COMMUNICATION SYSTEM - A user equipment for handling an attach procedure with a service network is provided. The user equipment comprises a wireless module transmitting an attach request message to the service network and receiving an attach accept message replied to the attach request message from the service network, and a controller determining whether to accept the attach accept message, sending an attach complete message, via the wireless module, to the service network in response to the attach accept message being accepted, and resending the attach request message, via the wireless module, to the service network in response to the attach accept message not being accepted. | 04-01-2010 |
| 20100081435 | APPARATUS AND METHOD FOR PERFORMING ATTACH PROCEDURE IN MOBILE COMMUNICATION SYSTEM - A service network for handling abnormal interrupts, including tracking area updates, lower layer failures, and guard timer expiries, during an attach procedure with a user equipment is provided. The service network includes a radio access network and a control node. When the radio access network detecting an abnormal interrupt, the control node aborts the attach procedure by sending a detach request message, via the radio access network, to the user equipment. | 04-01-2010 |
| 20120100850 | APPARATUS, SYSTEM, AND METHODS FOR HANDLING ATTACH PROCEDURE IN MOBILE COMMUNICATION SYSTEM - A user equipment for handling an attach procedure with a service network is provided. In the user equipment, a wireless module transmits an attach request message to the service network and receives an attach accept message replied to the attach request message from the service network, while a controller determines whether to accept the attach accept message according to a first parameter accompanying the attach accept message and sends an attach complete message, via the wireless module, to the service network in response to the attach accept message being accepted. | 04-26-2012 |
Joseph J. Huang, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110222774 | IMAGE FEATURE DETECTION BASED ON APPLICATION OF MULTIPLE FEATURE DETECTORS - In a particular embodiment, a method includes applying a first feature detector to a portion of an image to detect a first set of features. The first set of features is used to locate a region of interest, and a boundary corresponding to the region of interest is determined. The method also includes displaying the boundary at a display. In response to receiving user input to accept the displayed boundary, a second feature detector is applied to an area of the image encapsulated by the boundary. | 09-15-2011 |
Joseph Jyh-Huei Huang, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090300525 | METHOD AND SYSTEM FOR AUTOMATICALLY UPDATING AVATAR TO INDICATE USER'S STATUS - A cellular or wireless mobile device includes a one or more sensors and a processor configured with software to receive data from the one or more sensors, calendar data and device settings, compare sensor, calendar, device settings data, and an authorization level of a requesting user to avatar selection criteria, and select an avatar based upon the comparison. By correlating sensor data, calendar data and device settings to a user's current status, the avatar selection criteria enables a processor to automatically select an avatar that reflects the user's current status. Others then can be informed of the user's current status by accessing the user's avatar. | 12-03-2009 |
| 20100260426 | SYSTEMS AND METHODS FOR IMAGE RECOGNITION USING MOBILE DEVICES - Implementations relate to systems and methods for real-time image recognition and mobile visual searching. A mobile device, such as a cellular phone, acquires an image and pre-processes the acquired image to generate a visual search query based on objects detected in the acquired image. The visual search query includes the acquired image or a query image extracted therefrom and metadata associated with the detected objects. The mobile device wirelessly communicates the visual search query to a remote server, and in response to the visual search query, the remote server recognizes an object in the query image based on the associated metadata. The remote server then generates information content based on the recognized object and communicates the information content to the mobile device to be presented via the mobile device. | 10-14-2010 |
Ken Shi Kun Huang, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090196913 | Anti-Alpha-V Immunoliposome Composition, Methods, and Uses - An immunoliposome composition targeted to the alpha-V-integrin subunit of integrin receptors comprised of ligand-targeted liposomes bearing at least one targeting-ligand derived from an antibody and having binding specificity for at least one integrin receptor comprising an alpha-V subunit including αvβ1, αvβ3 αvβ5, αvβ6, or αvβ8 integrin cell receptors is described. The antibody-derived targeting ligand may be a Fab′ fragment, a scFv, or a the like. Binding of the immunoliposome to αv-integrin expressing cells, preferably results in internalization of the immunoliposome for cytoplasmic delivery of a liposome-entrapped agent. | 08-06-2009 |
Liming Huang, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100056506 | SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS - The present invention relates to compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof, wherein: R | 03-04-2010 |
| 20110172202 | SELECTIVE SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS AND METHODS OF CHIRAL SYNTHESIS - Compounds that selectively modulate the sphingosine 1 phosphate receptor are provided including compounds which modulate subtype 1 of the S1P receptor. Methods of chiral synthesis of such compounds is provided. Uses, methods of treatment or prevention and methods of preparing inventive compositions including inventive compounds are provided in connection with the treatment or prevention of diseases, malconditions, and disorders for which modulation of the sphingosine 1 phosphate receptor is medically indicated. | 07-14-2011 |
| 20110178056 | SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS AND METHODS OF CHIRAL SYNTHESIS - Compounds that selectively modulate the sphingosine 1 phosphate receptor are provided including compounds which modulate subtype 1 of the S1P receptor. Methods of chiral synthesis of such compounds is provided. Uses, methods of treatment or prevention and methods of preparing inventive compositions including inventive compounds are provided in connection with the treatment or prevention of diseases, malconditions, and disorders for which modulation of the sphingosine 1 phosphate receptor is medically indicated. | 07-21-2011 |
| 20110183953 | SELECTIVE HETEROCYCLIC SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS - Compounds that selectively modulate the sphingosine 1 phosphate receptor are provided including compounds which modulate subtype 1 of the S1P receptor. Methods of chiral synthesis of such compounds is provided. Uses, methods of treatment or prevention and methods of preparing inventive compositions including inventive compounds are provided in connection with the treatment or prevention of diseases, malconditions, and disorders for which modulation of the sphingosine 1 phosphate receptor is medically indicated. | 07-28-2011 |
| 20110306542 | NOVEL GLP-1 RECEPTOR STABILIZERS AND MODULATORS - Compounds that bind the glucagon-like peptide 1 receptor (GLP-1) receptor are provided including compounds which are modulators of the GLP-1 receptors and compounds which are capable of inducing a stabilizing effect on the receptor for use in structural analyses of the GLP-1 receptor. Methods of synthesis, methods of therapeutic and/or prophylactic use, and methods of use in stabilizing GLP-1 receptor in vitro for crystallization of the GLP-1 receptor of such compounds are provided. | 12-15-2011 |
| 20120035194 | SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS - The present invention relates to compounds of formula (I), | 02-09-2012 |
Liying Huang, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120097351 | HIGHLY ABSORBENT AND RETENTIVE FIBER MATERIAL - A process for producing a water-absorbent high-porosity fibrous matrix from lignocellulosic raw materials, comprising wet mechanical processing of the raw material, drying, and then dry mechanical processing the fibers to provide a fibrous matrix is provided. The high-porosity fibrous matrix and absorbent articles prepared therefrom are also provided. | 04-26-2012 |
Lun Bin Huang, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110167322 | Methods to improve ACS performance - In one embodiment, systems and methods of operating a SOVA system is disclosed that comprises determining the start and stop values for a trellis tree and using the start and stop values to determine the initial states of a plurality of branches within the trellis tree. | 07-07-2011 |
| 20110197112 | Max-log-map equivalence log likelihood ratio generation soft Viterbi architecture system and method - A modified soft output Viterbi algorithm (SOVA) detector receives a sequence of soft information values and determines a best path and an alternate path for each soft information value and further determines, when the best and alternate paths lead to the same value for a given soft information value, whether there is a third path departing from the alternate path that leads to an opposite decision with respect to the best path for a given soft information value. The SOVA detector then considers this third path when updating the reliability of the best path. The modified SOVA detector achieves max-log-map equivalence effectively through the Fossorier approach and includes modified reliability metric units for the first N stages of the SOVA detector, where N is the memory depth of a given path, and includes conventional reliability metric units for the remaining stages of the detector. | 08-11-2011 |
Mingxian Huang, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080286750 | APPARATUS INCLUDING ION TRANSPORT DETECTING STRUCTURES AND METHODS OF USE - The present invention recognizes that the determination of ion transport function or properties using direct detection methods, such as whole cell recording or single channel recording, are preferable to methods that utilize indirect detection methods, such as FRET based detection system. The present invention provides biochips and other fluidic components and methods of use that allow for the direct analysis of ion transport function or properties using microfabricated structures that can allow for automated detection of ion transport function or properties. These biochips and fluidic components and methods of use thereof are particularly appropriate for automating the detection of ion transport function or properties, particularly for screening purposes. | 11-20-2008 |
| 20090209029 | HIGH-DENSITY ION TRANSPORT MEASUREMENT BIOCHIP DEVICES AND METHODS - The present invention includes biochips for the measurement of cellular ion channels and methods of use and manufacture. The biochips of the present invention have enhanced sealing capabilities provided in part by chemically modifying the surface of the biochip surface or substrate or by exposure to an ionized gas. The present invention also includes novel cartridges for biochips. | 08-20-2009 |
| 20100260984 | MICRODEVICES CONTAINING PHOTORECOGNIZABLE CODING PATTERNS AND METHODS OF USING AND PRODUCING THE SAME - This invention relates generally to the field of moiety or molecule analysis, isolation, detection and manipulation and library synthesis. In particular, the invention provides a microdevice, which microdevice comprises: a) a substrate; and b) a photorecognizable coding pattern on said substrate. Preferably, the microdevice does not comprise an anodized metal surface layer. Methods and kits for isolating, detecting and manipulating moieties, and synthesizing libraries using the microdevices are also provided. The invention further provides two-dimensional optical encoders and uses thereof. In certain embodiments, the invention provides a microdevice, which microdevice comprises: a) a magnetizable substance; and b) a photorecognizable coding pattern, wherein said microdevice has a preferential axis of magnetization. Systems and methods for isolating, detecting and manipulating moieties and synthesizing libraries using the microdevices are also provided. | 10-14-2010 |
Mingxiang Huang, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080200349 | MICRODEVICES HAVING A PREFERENTIAL AXIS OF MAGNETIZATION AND USES THEREOF - This invention relates generally to the field of moiety or molecule isolation, detection and manipulation and library synthesis. In particular, the invention provides a microdevice, which microdevice comprises: a) a magnetizable substance; and b) a photorecognizable coding pattern, wherein said microdevice has a preferential axis of magnetization. Systems and methods for isolating, detecting and manipulating moieties and synthesizing libraries using the microdevices are also provided. | 08-21-2008 |
Qihong Huang, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100275284 | INHIBITOR OF APOPTOSIS PROTEINS AND NUCLEIC ACIDS AND METHODS FOR MAKING AND USING THEM - The invention provides polypeptides comprising inhibitor of apoptosis protein (IAP) family members, such as BmIAP initially derived from | 10-28-2010 |
Shenlin Huang, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080293785 | SUBSTITUTED BENZOTHIAZOLE KINASE INHIBITORS - The present invention is directed to substituted benzothiazole compounds of formula (I): | 11-27-2008 |
| 20090048249 | 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders - The present invention is directed to novel 3-benzoimidazolyl-pyrazolopyridine compounds of formula (I): | 02-19-2009 |
| 20100029605 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS - The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, ARG, BCR-Abl, BRK, EphB, Fms, Fyn, KDR, c-Kit, LCK, PDGF-R, b-Raf, c-Raf, SAPK2, Src, Tie2 and TrkB kinases. | 02-04-2010 |
| 20100168182 | COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS - The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly TrkA, TrkB, TrkC, PDGFR and c-kit. | 07-01-2010 |
| 20100184765 | Protein Kinase Inhibitors and Methods for Using Thereof - The invention provides compounds and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, and methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of Alk, Abl, Aurora-A, B-Raf, C-Raf, Bcr-Abl, BRK, Blk, Bmx, BTK, C-Kit, CSK, C-Src, EphB1, EphB2, EphB4, FLT1, Fms, Flt3, Fyn, FRK3, JAK2, KDR, Lck, Lyn, PDGFRα, PDGFRβ, PKCα, SAPK2α, Src, SIK, Syk, Tie2 and TrkB kinases. | 07-22-2010 |
| 20110052578 | Compounds and Compositions as Protein Kinase Inhibitors - The present invention provides compounds of Formula I or II: | 03-03-2011 |
| 20110306625 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS - The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf. | 12-15-2011 |
Wenhu Huang, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100031378 | Novel gene disruptions, compositions and methods relating thereto - The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO227, PRO233, PRO238, PRO1328, PRO4342, PRO7423, PRO10096, PRO21384, PRO353 or PRO1885 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities. | 02-04-2010 |
| 20110093960 | Methods of identifying agents that ameliorate or modulate effects of PRO1328 gene disruptions - The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO227, PRO233, PRO238, PRO1328, PRO4342, PRO7423, PRO10096, PRO21384, PRO353 or PRO1885 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities. | 04-21-2011 |
| 20110097330 | Novel Gene Disruptions, Compostitions and Methods Relating Thereto - The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO179, PRO181, PRO244, PRO247, PRO269, PRO293, PRO298, PRO339, PRO341, PRO347, PRO531, PRO537, PRO718, PRO773, PRO860, PRO871, PRO872, PRO813, PRO828, PRO1100, PRO1114, PRO115, PRO1126, PRO1133, PRO1154, PRO1185, PRO1194, PRO1287, PRO1291, PRO1293, PRO1310, PRO1312, PRO1335, PRO1339, PRO2155, PRO1356, PRO1385, PRO1412, PRO1487, PRO1758, PRO1779, PRO1785, PRO1889, PRO90318, PRO3434, PRO3579, PRO4322, PRO4343, PRO4347, PRO4403, PRO4976, PRO260, PRO6014, PRO6027, PRO6181, PRO6714, PRO9922, PRO7179, PRO7476, PRO9824, PRO19814, PRO19836, PRO20088, PRO70789, PRO50298, PRO51592, PRO1757, PRO4421, PRO9903, PRO1106, PRO1411, PRO1486, PRO1565, PRO4399 or PRO4404 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities. | 04-28-2011 |
Xuhao Huang, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110063005 | DELAY-LOCKED LOOP HAVING A DELAY INDEPENDENT OF INPUT SIGNAL DUTY CYCLE VARIATION - A Delay-Locked Loop (DLL) uses a delay line to delay a first signal by a “delay time”, thereby generating a second signal. A capacitor is charged at a first rate starting at a first edge of first signal and continuing until an edge of the second signal. The capacitor is then discharged at a second rate until another edge of the first signal. A control loop controls the delay time such that the amount the capacitor is charged is the same as the amount the capacitor is discharged. The delay time is constant and is substantially independent of variations in the duty cycle of the first signal. In one example, duty cycle distortion cancellation is accomplished by changing the first rate proportionally with respect to changes in first signal duty cycle. In another example, the first and second rates are independent of the duty cycle of the first signal. | 03-17-2011 |
Yuheng Huang, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080220723 | COHERENT INITIAL ACQUISITION - An acquisition module includes a coherent correlator configured to receive a transmission having a pilot signal and correlate the received transmission with a local copy of the pilot signal to produce a first output, a delayed correlator configured to delay the first output and correlate the first output with the delayed first output to produce a second output, and a detector configured to detect the pilot signal in the transmission based on the second output. | 09-11-2008 |
| 20100062705 | APPARATUS AND METHOD FOR INTERFERENCE-ADAPTIVE COMMUNICATIONS - In embodiments, an adaptive tone erasure technique is applied to orthogonal frequency division multiplexing (OFDM) communications, such as ECMA-368 standard ultra-wideband (UWB) communications. A transmitter obtains jammed sub-carrier information and calculates an erasure mask. The jammed sub-carriers are nulled before transmitting to a receiver. In accordance with the erasure mask, bits falling on the jammed sub-carriers are replaced by erasure bits before interleaving, keeping the interleaver block size constant notwithstanding variations in the number of the jammed sub-carriers. The receiver also obtains the jammed sub-carrier information and the erasure mask. After the receiver deinterleaves the constant size blocks, it decodes the data without the erasure bits. The transmitter may detect the jammed sub-carriers itself, or obtain the information from the receiver. The receiver similarly may detect the jammed sub-carriers itself, or obtain the information from the transmitter. | 03-11-2010 |
| 20100278290 | TRAFFIC-TO-PILOT RATIO ESTIMATION FOR MIMO-OFDM SYSTEM - A method for estimating a traffic-to-pilot ratio (TPR) for a received signal is disclosed. The received signal is despatialized to obtain a despatialized received signal. A channel matrix is despatialized to obtain a despatialized channel matrix. The despatialized received signal is whitened to obtain a pre-whitened despatialized received signal. The despatialized channel matrix is whitened to obtain a pre-whitened despatialized channel matrix. The estimated TPR for the received signal is determined using the pre-whitened despatialized received signal and one or more pre-whitened despatialized channel estimation coefficients. | 11-04-2010 |
| 20110150152 | SYSTEMS AND METHODS PROVIDING FREQUENCY-DOMAIN AUTOMATIC GAIN CONTROL (AGC) - A method for Automatic Gain Control (AGC) in a receiver is performed by a circuit having an inner loop and an outer loop. The method includes performing an outer loop energy detection, mitigating interference using the outer loop energy detection, and performing a frequency domain energy measurement in the inner loop. The method also includes adjusting a digital gain component in the inner loop and an analog gain component in the outer loop in response to the frequency domain energy measurement. | 06-23-2011 |
Yujin Huang, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090326251 | METHODS FOR PREPARING 17-ALKYNYL-7-HYDROXY STEROIDS AND RELATED COMPOUNDS - The invention relates to processes for preparing 17-alkynyl-7-hydroxy-steroids, such as 17-Ethynyl-10R,13S-dimethyl 2,3,4,7,8R,9S, 10,11,12,13,14S,15,16,17-hexadecahydro-1H-cyclopenta[a]phenanthrene-3R,7R,17S-triol (also referred to as 17α-ethynyl-androst-5-ene-3β,7β,17β-triol), that are essentially free of process impurities having binding activity at nuclear estrogen receptors. | 12-31-2009 |
| 20100016259 | Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators - The present invention relates to novel compounds (I), their prodrugs, and the pharmaceutically acceptable salts as well as pharmaceutical compositions containing such compounds useful in treating certain metabolic diseases and diseases modulated by the inhibition of the enzyme malonyl-coenzyme A decarboxylase (malonyl-CoA decarboxylase, MCD). In particular, the invention relates to compounds and compositions and the methods for the prophylaxis, management and treatment of cardiovascular diseases, diabetes, acidosis, cancers, and obesity through the inhibition of malonyl-coenzyme A decarboxylase. | 01-21-2010 |